America is beginning to see cannabis as an alternative to prescription pills. Israel is years ahead – and its entrepreneurs want to curb a crisis of opioid addiction that is completely out of control.
Eight Years And $83 Million Later, Syqe® Medical Releases First Cannabis Inhaler
Teva will market the company’s inhalers exclusively in Israel, after signing a marketing and distribution agreement with Syqe® in 2016.